Identity of original and late passage Dami megakaryocytes with HEL erythroleukemia cells shown by combined cytogenetics and DNA fingerprinting

Leukemia

Volumn 11, Issue 12, 1997, Pages 2032-2038

  MacLeod, Raf ^a   Dirks, W G ^a   Reid, Y A ^b   Hay, R J ^b   Drexler, H G ^a  

^a LEIBNIZ INSTITUTE DSMZ GERMAN COLLECTION OF MICROORGANISMS AND CELL CULTURES   (Germany)

^b AMERICAN TYPE CULTURE COLLECTION   (United States)

Author keywords

Cell lines; Dami; HEL; Leukemia

Indexed keywords

DNA;

ARTICLE; CANCER CELL CULTURE; CHROMOSOME 18; CHROMOSOME 21; CHROMOSOME 5; CONTROLLED STUDY; CYTOGENETICS; DNA FINGERPRINTING; ERYTHROLEUKEMIA CELL; HUMAN; HUMAN CELL; KARYOTYPING; MEGAKARYOCYTE; PRIORITY JOURNAL; STRUCTURAL CHROMOSOME ABERRATION;

EID: 0031451136     PISSN: 08876924     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.leu.2400868     Document Type: Article

References (17)

1. Hay RJ, Reid YA, McClintock PR, Chen TR, Macy ML. Cell line banks and their role in cancer research. J Cell Biochem 1996; 24 (Suppl): 107-130.
2. Greenberg SM, Rosenthal DS, Greeley TA, Tantravahi R, Handin R I. Characteristics of a new megakaryocytic cell line: the Dami cell. Blood 1988; 72: 1968-1977.
3. Martin P, Papayannopoulou T. HEL cells: a new human erythroleukemia cell line with spontaneous and induced globin expression. Science 1982; 216: 1233-1235.
4. ISCN 1995. An International System for Human Cytogenetic Nomenclature. Mitelman F (ed). S Karger: Basel, 1995.
5. Horn GT, Richards B, Klinger W. Amplification of a highly polymorphic VNTR segment by the polymerase chain reaction. Nucleic Acids Res 1989; 17: 2140-2142.
6. Ludwig EH, Walter F, McCarthy BJ. High-resolution analysis of a hypervariable region in the human apolipoprotein B gene. Am J Hum Genet 1989; 45: 458-164.
7. Budowle B, Chakraborty R, Giusti AM, Eisenberg AJ, Allen RC. Analysis of the VNTR locus D1S80 by the PCR followed by high-resolution RAGE. Am J Hum Genet 1991; 48: 137-144.
8. Heim S, Mitelman F. Cancer Cytogenetics, 2nd edn. Wiley Liss: New York, 1995.
9. Drexler HG, Dirks WG, MacLeod RAF, Quentmeier H, Steube K, Uphoff C (eds). Catalogue of Human and Animal Cell Lines, 6th edn. DSMZ: Braunschweig, 1997.
10. Berg LP, Shamsher MK, El-Daher SS, Kakkar VV, Authi KS. Expression of human TRPC genes in the megakaryocytic cell lines MEG01, DAMI and HEL. FEBS Lett 1997; 403: 83-86.
11. Mohle R, Green D, Moore MA, Nachman RL, Rafii S. Constitutive production and thrombin-induced release of vascular endothelial growth factor by human megakaryocytes and platelets. Proc Natl Acad Sci USA 1997; 94: 663-668.
12. Tani T, Ylanne J, Virtanen I. Expression of megakaryocytic and erythroid properties in human leukemic cells. Exp Hematol 1996; 24: 158-168.
13. Kiss C, Surrey S, Schreiber AD, Schwartz E, McKenzie SE. Human c-kit ligand (stem cell factor) induces platelet Fc receptor expression in megakaryoblastic cells. Exp Hematol 1996; 24: 1232-1237.
14. Philippeaux MM, Vesin C, Tacchini-Cottier F, Piguet PF. Activated human platelets express beta2 integrin. Eur J Haematol 1996; 56: 130-137.
15. Razdan K, Kroll MH. Molecular cloning of a novel platelet protein showing homology to the angiotensin II receptor C-terminal domain. J Biol Chem 1996; 271: 2221-2224.
16. Lebeurier I, Basara N, Aidoudi S, Amiral J, Caen JP, Han ZC. Carboxy-terminal peptides (C1-24 and CI 3-24 but not C1-13) of platelet factor 4 inhibit murine megakaryocytopoiesis, an activity which is neutralized by heparin. Br J Haematol 1996; 92: 29-34.
17. O'Rourke F, Matthews E, Feinstein MB. Purification and characterization of the human type 1 lns(1,4,5)P3 receptor from platelets and comparison with receptor subtypes in other normal and transformed blood cells. Biochem J 1995; 312: 499-503.